Escape Therapeutics has successfully worked on a number of novel and potentially disruptive technologies including peptides/ proteins and some of them are already in the market, either by themselves, or in collaboration, and has also out-licensed portfolios in the past. Their various technologies/ products can be applied for treating conditions such as Type I diabetes, Myocardial infarction and Chronic heart failure, Osteoarthritis, Scleroderma, thermal burn and radiation injury, Hyperpigmentation, Melanoma, Aging, Wound and scar etc. Escape Therapeutics is currently looking for licensing/sale of their Patent Portfolio (including stake in the entity as well) and/or for allied collaborations.
For more details about the technology: Click Here